Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, and CAR-T cell therapy research.
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics
The activation of the adaptor protein STING depends on its interactions with the phospholipid PI4P
Induced CD45 Proximity Potentiates Natural Killer Cell Receptor Antagonism
584 Powerful synergistic effects of a STING agonist and the IL-2 superkine, H9, in eliciting NK and T cell responses against MHC I- and MHC I+ tumors
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
Listening to each other: Infectious disease and cancer immunology
Neutrophils Suppress Intraluminal NK Cell–Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells
Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
Regulation of Ligands for the NKG2D Activating Receptor